KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,616,000 | +12.9% | 479,124 | -6.7% | 0.22% | +13.3% |
| Q2 2022 | $2,317,000 | -59.5% | 513,802 | -33.8% | 0.20% | -56.3% |
| Q1 2022 | $5,720,000 | -46.3% | 776,053 | -53.2% | 0.45% | -34.1% |
| Q4 2021 | $10,661,000 | +20.7% | 1,658,047 | +9.2% | 0.68% | +24.0% |
| Q3 2021 | $8,834,000 | -37.8% | 1,517,804 | +10.3% | 0.55% | -23.8% |
| Q2 2021 | $14,204,000 | +62.7% | 1,376,372 | +65.9% | 0.72% | +24.4% |
| Q1 2021 | $8,728,000 | – | 829,681 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |